246 related articles for article (PubMed ID: 18937843)
1. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
3. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.
Kodama J; Shinyo Y; Hasengaowa ; Kusumoto T; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Oncol Rep; 2005 Jul; 14(1):89-92. PubMed ID: 15944773
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
Sakaguchi H; Fujimoto J; Hong BL; Tamaya T
Cancer Lett; 2007 Mar; 247(1):98-102. PubMed ID: 16675104
[TBL] [Abstract][Full Text] [Related]
5. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Wen H; Tamaya T
Cancer Res; 1999 Jul; 59(13):3041-4. PubMed ID: 10397240
[TBL] [Abstract][Full Text] [Related]
7. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
Wu SH; Zhang J; Li Y; Li JM
Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
[TBL] [Abstract][Full Text] [Related]
8. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
9. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in early stage cervical cancer.
Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
[TBL] [Abstract][Full Text] [Related]
12. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
15. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Yu W; Liu J; Xiong X; Ai Y; Wang H
Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].
Goudy G; Stoeckle E; Thomas L; Kind M; Guyon F; Brouste V; Floquet A
Bull Cancer; 2009 Jun; 96(6):685-94. PubMed ID: 19467961
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation.
Sánchez-Hernández PE; Ramirez-Dueñas MG; Albarran-Somoza B; García-Iglesias T; del Toro-Arreola A; Franco-Topete R; Daneri-Navarro A
Gynecol Oncol; 2008 Jan; 108(1):19-26. PubMed ID: 17936340
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
[TBL] [Abstract][Full Text] [Related]
20. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
